MARINUS PHARMACEUTICALS, INC.
CIK 0001267813
Revenue (TTM)
$8.99M
Q3 Nov 2024
Net Income (TTM)
−$131.69M
−613.6% YoY
Q3 Nov 2024
EPS Diluted (TTM)
−$2.34
−415.7% YoY
Q3 Nov 2024
Gross Margin
83.6%
Q3 Nov 2024
Operating Margin
-1,344.0%
Q3 Nov 2024
Net Margin
-1,465.4%
Q3 Nov 2024
Free Cash Flow (TTM)
−$122.8M
Q3 Nov 2024
Cash
$42.18M
Q3 Nov 2024
Total Debt
$59.75M
Q3 Nov 2024
Shares Outstanding
55.19M sh
Q3 Nov 2024
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.